|Year : 2007 | Volume
| Issue : 3 | Page : 116-119
Role of fine needle aspiration cytology in the management of pediatric renal tumors
Venkateswaran K Iyer
Department of Pathology, All India Institute of Medical Sciences, New Delhi, India
Venkateswaran K Iyer
Department of Pathology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi - 110 029
| Abstract|| |
Fine needle aspiration cytology (FNAC) is a useful pre-operative procedure in pediatric renal tumors. It is a safe technique that does not upstage the tumor and permits positive diagnosis of Wilm's tumor in almost all aspirates with use of immunocytochemistry for cytokeratin and WT-1. Advanced information on diagnosis of Wilm's tumor, especially, the presence of stroma predominance or anaplastic change is a guide to selection and monitoring of chemotherapy. Early diagnosis of clear cell sarcoma of the kidney (CCSK) by FNAC helps in the evaluation of bone metastasis and selection of Doxorubicin-based chemotherapy protocols to which the tumor is responsive. Thus, the routine use of FNAC is helpful for further investigation and management of pediatric renal masses.
Keywords: Children, fine needle aspiration cytology, renal tumors
|How to cite this article:|
Iyer VK. Role of fine needle aspiration cytology in the management of pediatric renal tumors. J Indian Assoc Pediatr Surg 2007;12:116-9
|How to cite this URL:|
Iyer VK. Role of fine needle aspiration cytology in the management of pediatric renal tumors. J Indian Assoc Pediatr Surg [serial online] 2007 [cited 2013 May 24];12:116-9. Available from: http://www.jiaps.com/text.asp?2007/12/3/116/34947
Fine needle aspiration cytology (FNAC) has been amply demonstrated to be a useful diagnostic modality in pediatric renal tumors. ,,,,, However, despite this, the exact role of FNAC in evaluation of renal masses of children is unclear and controversial. Primary renal neoplasms on radiology, which are amenable to surgery, require primary resection. This makes the entire specimen available for histopathological evaluation, thereby obviating the need for FNAC prior to operation. On the other hand, inoperable renal tumors require FNAC or biopsy for diagnosis prior to appropriate chemotherapy. FNAC is useful in this situation because in addition to making a positive diagnosis of Wilm's tumor (WT), anaplastic changes of unfavorable WT histology have been seen in aspirates, , which may help in selection of the chemotherapy regimen. Other rare pediatric renal tumors like clear cell sarcoma of kidney (CCSK) may be diagnosed prior to starting the chemotherapy. , Despite FNAC being a good evaluative technique, increasingly, trucut needle biopsy is being preferred,  owing largely to pathologists being unfamiliar with FNAC morphology and the ease of performing immunohistochemistry and molecular biology studies on the biopsy material. It is important to emphasize that neither trucut biopsy nor FNAC upstages pediatric renal tumors.  However, the safety of FNAC in this situation is incontrovertible.
Through the 1990s, the All India Institute of Medical Sciences has followed a policy of FNAC being performed in an out-patient setting without anesthesia, in preference to biopsy, in all pediatric tumors. However, in renal tumors, FNAC was performed only in late stage inoperable patients before starting a pre-operative chemotherapy, following the above detailed rationale. FNAC in operable tumors was performed sometimes only when the diagnosis was in doubt on radiological evaluation. Despite this limitation, large numbers of FNACs were performed, and in 2003, a review of a 17-year material found 119 adequate pediatric renal aspirates.  This review prompted a rethink, and since 2003, we are performing routine FNAC in all renal tumors of childhood prior to operation.
The vast majority of renal tumors in children are WT. FNAC appearance of WT has been well documented on small series of 15 to 20 cases, ,,, including an earlier study from our institution based on an experience of 23 aspirates.  Aspirates from WT are cellular and show blastema, tubules, and mesenchyme [Figure - 1]. Diagnosis of WT on aspirates that are triphasic or biphasic (with blastema and tubules) is easily accomplished on cytology. However, aspirates showing either only blastema or blastema accompanied by scant mesenchyme, present diagnostic difficulty. Frequently, a diagnosis of non-specific malignant round cell tumor is provided, which is of no value to the treating surgeon. Due to this, FNAC has been unfavorable with most pediatric surgeons. In our institution, 110 out of 119 adequate aspirates from pediatric renal tumors were WT.  Aspirates were triphasic in 44 cases (40%), biphasic (blastema and tubules) in 36 cases (32.73%), and monophasic (blastema alone) in 30 cases (27.27%). Thus, FNAC diagnosis of WT (triphasic or biphasic) is possible in over two-thirds of patients. One-third has blastema alone, and diagnosis is therefore difficult. Cytokeratin immunostaining is useful in this regard,  and one-third of only blastema aspirates from WT have focal cytokeratin positive cells, showing focal epithelial differentiation, which is not otherwise evident on cytomorphology. Recently, WT-1 immunocytochemistry is available, which is always positive in the blastemal cells of WT, except rare instances where both copies of the WT-1 gene are mutated. It is the WT-1 protein which is responsible for blastemal differentiation. We have performed immunocytochemistry for WT-1 on WT aspirates subsequent to 2003 and have found WT-1 to be strongly positive on FNAC smears, with good correlation between histology and cytology [Figure - 2]. Even poor aspirates with very few tumor cells light up with the WT-1 immunocytochemical stain. Hence, positive diagnosis was possible in aspirates which otherwise would have been reported as scant aspirate with few cells from a malignant round cell tumor. A positive diagnosis of WT is almost always possible on FNAC with use of WT-1 immucytochemistry. Cytomorphology alone is enough for diagnosis of two-thirds of aspirates while immunocytochemistry can resolve the remaining one-third as well. Therefore, FNAC is a useful and less invasive alternative to biopsy.
Stromal predominance was seen in 10% of our WT aspirates [Figure - 3], including presence of rhabdomyoblastic differentiation in some instances. Stroma predominance on cytology correlates well with histology and may be an early indicator of chemoresistance. , Rhabdomyoblastic differentiation is easy to identify and differentiate from the exceptionally rare pediatric renal rhabdomyosarcoma.  Anaplastic (unfavorable) cytological features can be identified on aspirates using criteria similar to histology, i.e., variation in nuclear size of three times or more, marked hyperchromasia with bizarre nuclei, and atypical mitotic figures in a biphasic or triphasic aspirate.  If anaplasia is found on FNAC, it is considered as an indication of diffuse anaplasia, which is important since it signifies chemoresistance.  When performed, FNAC determines diffuse anaplasia at all instances [Figure - 4].
Thus, the main advantage of FNAC in WT is the availability of advanced information before the institution of chemotherapy. Cases with stroma predominance, which do not shrink with chemotherapy and do not behave aggressively, and anaplastic WT, which are chemoresistant, can be separated out. In the latter, a different chemotherapy protocol is indicated.  However, so far, the most important advantage of pre-operative FNAC is the diagnosis of CCSK. Of 119 patients, CCSK was diagnosed in 8 patients and rhabdoid tumor in 1 patient. 
CCSK, also known as bone metastasis tumor, is not uncommon and forms around 5% of pediatric renal tumors. , We found 8 of 119 aspirates (6.72%) to be CCSK; however, this high incidence was mainly among late stage inoperable patients.  CCSK has a poor outcome compared to WT  and requires a separate chemotherapy regimen incorporating doxorubicin to which it is sensitive.  Most cases of CCSK present late and are inoperable in many instances. Pre-operative diagnosis is, therefore, important and possible with FNAC. ,,,, CCSK differs from WT in its propensity for bone metastasis and needs to be investigated accordingly. Thus, FNAC is a useful guide to further management. The histology of CCSK is only recently described with a large published series.  Our experience with FNAC features of CCSK is the largest available to date. 
Diagnosis of CCSK on FNAC is a challenge for the cytopathologist because it has many variant patterns. These variations are presently considered as alterations of two kinds of cell types, cord, and septal cells. Septal cells are spindle shaped whereas cord cells are polygonal in shape.  It is possible to identify these cells on cytology and this forms the key to diagnosis.  The cytopathologist has to be aware of the variable extent of these two cell types, which can be present in aspirates, because sampling of septal cells can lead to a false identification of a "biphasic" pattern and misdiagnosis as WT.  Entrapped normal tubules are a feature of CCSK on histology and benign tubular epithelial cells are also commonly seen on FNAC material.  These should not be misinterpreted as tubular differentiation of the tumor cells with a misdiagnosis of WT. Cytoplasmic and nuclear features of cord cells are characteristic. The optically clear nuclei of CCSK on histology are seen as fine powdery chromatin on cytology and there are nuclear grooves. Presence of cytoplasm is the most useful criterion [Figure - 5]. Stromal fragments are composed of septal cells and are embedded in a myxoid matrix which is never seen in WT.
It is important to emphasize that CCSK on FNAC has a variable appearance and knowledge of this variability of cytological features is needed for accurate diagnosis. Unlike WT, there is no positive immunocytochemical marker for CCSK.  Vimentin shows focal positivity, but is much more strongly positive in primitive neuroectodermal tumors and pheochromocytoma, both of which can arise close to the kidney, can resemble CCSK on aspirates, and have a propensity for bone metastasis. CCSK is negative for almost all other immunocytochemical markers, including WT-1. Hence, a complete immunocytochemical panel including vimentin, cytokeratin, WT-1, Mic-2, desmin, and markers for neural differentiation are needed for the diagnosis of CCSK. , Negativity for all these other markers is of more importance than positivity for vimentin. In the context of differentiating WT and CCSK, immunocytochemistry for WT-1 is useful, being positive in WT but negative in CCSK. In correlation with radiology, clinical presentation and biochemical findings are also essential.
To conclude, a positive diagnosis of WT on FNAC can be made on morphology and immunocytochemistry in almost all instances. The main advantage of pre-operative FNAC is the early identification of stroma predominance, anaplastic change, and separation from CCSK. Around 10-15% of pediatric renal aspirates have these features. Early availability of this information is useful in further investigations like skeletal survey, bone scan, and PET scan and the chemotherapy protocols to be selected. , This is especially so in CCSK, since when compared stage for stage with WT and using current management, CCSK has a better outcome than previously thought and approaches the good outcome of WT. 
| References|| |
|1.||Quijano D, Drut R. Cytologic characteristics of Wilms' tumors in fine needle aspirates. A study of ten cases. Acta Cytol 1989;33:263-6. |
|2.||Dey P, Radhika S, Rajwanshi A, Rao KL, Khajuria A, Nijhawan R, et al . Aspiration cytology of Wilms' tumor. Acta Cytol 1993;37:477-82. |
|3.||Hazarika D, Narasimhamurty KN, Rao CR, Gopinath KS. Fine needle aspiration cytology of Wilms tumor: A study of 17 cases. Acta Cytol 1994;38:355-60. |
|4.||Schmidt D, Beckwith JB. Histopathology of childhood renal tumors. Hematol Oncol Clin North Am 1995;9:1179-200. |
|5.||Iyer VK, Kapila K, Agarwal S, Dinda AK, Verma K. Role of fine needle aspiration and ploidy by image analysis in the prognostication of Wilms tumour. Anal Quant Cytol Histol 1999;21:505-11. |
|6.||Drut R, Pollono D. Anaplastic Wilms' tumor. Initial diagnosis by fine needle aspiration. Acta Cytol 1987;31:774-6. |
|7.||Radhika S, Bakshi A, Rajwanshi A, Nijhawan R, Das A, Kakkar N, et al . Cytopathology of uncommon renal neoplasms in the pediatric age group. Diagn Cytopathol 2005;32:281-6. |
|8.||Iyer VK, Agarwala S, Verma K. Fine needle aspiration cytology of clear cell sarcoma of the kidney: Study of eight cases. Diagn Cytopathol 2005;33:83-9. |
|9.||Vujanic GM, Kelsey A, Mitchell C, Shannon RS, Gornall P. The role of biopsy in the diagnosis of renal tumors of childhood: Results of the UKCCSG Wilms tumor study 3. Med Pediatr Oncol 2003;40:18-22. |
|10.||Brahmi U, Rajwanshi A, Joshi K, Ganguly NK, Vohra H, Gupta SK, et al . Role of immunocytochemistry and DNA flow cytometry in the fine-needle aspiration diagnosis of malignant small round-cell tumors. Diagn Cytopathol 2001;24:233-9. |
|11.||Saba LM, de Camargo C, Gabriel-Aran M. Experience with six children with Fetal rhabdomyomatous nephroblastoma: Review of the clinical, biologic and pathologic features. Med Pediatr Oncol 1998;30:152-5. |
|12.||Fernandes ET, Parham DM, Ribeiro RC, Douglass EC, Kumar AP, Wilimas J. Teratoid Wilms' tumor: The St. Judes experience. J Pediatr Surg 1988;23:1131-4. |
|13.||Iyer VK, AlSalti W, Morland B, Parkes S. Embryonal rhabdomyosarcoma of the kidney in childhood. Ann Diagn Paediatr Pathol 2000;4:31-4. |
|14.||Green DM, Breslow NE, Beckwith JB, Moksness J, Finklestein JZ, D'Angio GJ. Treatment of children with clear-cell sarcoma of the kidney: A report from the National Wilms' Tumor Study Group. J Clin Oncol 1994;12:2132-7. |
|15.||Argani P, Perlman EJ, Breslow NE, Browning NG, Green DM, D'Angio GJ, et al . Clear cell sarcoma of the kidney. A review of 351 cases from the National Wilms' Tumor Study Group pathology centre. Am J Surg Pathol 2000;24:4-18. |
|16.||Sotelo-Avila C, Gonzalez-Crussi F, Sadowinski S, Gooch WM 3 rd , Pena R. Clear cell sarcoma of the kidney: A clinicopathologic study of 21 patients with long-term follow-up evaluation. Hum Pathol 1985;16:1219-30. |
|17.||Seibel NL, Li S, Breslow NE, Beckwith JB, Green DM, Haas GM, et al . Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: A report from the National Wilms' Tumor Study Group. J Clin Oncol 2004;22:468-73. |
|18.||Sharifah NA. Fine needle aspiration cytology characteristics of renal tumors in children. Pathology 1994;26:359-64. |
|19.||Akhtar M, Ali MA, Sackey K, Burgess A. Fine needle aspiration biopsy of clear-cell sarcoma of the kidney: Light and electron microscopic features. Diagn Cytopathol 1988;5:181-7. |
|20.||Drut R, Pomar M. Cytological characteristics of clear- cell sarcoma of the kidney (CCSK) in fine needle aspiration biopsy (FNAB): A report of 4 cases. Diagn Cytopathol 1991;7:611-4. |
|21.||Iyer VK, Kapila K, Verma K. Fine needle aspiration cytology of clear cell sarcoma of the kidney with spindle cell pattern. Cytopathology 2003;14:160-4. |
|22.||Looi LM, Cheah PL. An immunohistochemical study comparing clear cell sarcoma of the kidney and Wilms' tumor. Pathology 1993;25:106-9. |
|23.||Cheah PL, Looi LM. Implications of p53 protein expression in clear cell sarcoma of the kidney. Pathology 1996;28:229-31. |
|24.||Metzger ML, Dome JS. Current Therapy for Wilms' Tumor. Oncologist 2005;10:815-26. |
[Figure - 1], [Figure - 2], [Figure - 3], [Figure - 4], [Figure - 5]